Healthcare | May 08, 2026
Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Supported by Plan International, the partnership will help treat over 1,000 children annually
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Subscribe To Our Newsletter & Stay Updated
